Credit Suisse’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $4.72M | Sell |
|
|||||
|
2023
Q4 | $7.4M | Buy |
|
|||||
|
2023
Q3 | $1.34M | Sell |
|
|||||
|
2023
Q2 | $2.31M | Buy |
|
|||||
|
2023
Q1 | $1.35M | Buy |
|
|||||
|
2022
Q4 | $1.75M | Buy |
|
|||||
|
2022
Q3 | $1.42M | Buy |
|
|||||
|
2022
Q2 | $1.28M | Buy |
|
|||||
|
2022
Q1 | $1.29M | Buy |
|
|||||
|
2021
Q4 | $1.04M | Buy |
|
|||||
|
2021
Q3 | $811K | Buy |
|
|||||
|
2021
Q2 | $391K | Buy |
|
|||||
|
2021
Q1 | $178K | Buy |
|